INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 13, 2003 |
Director
Trans History: 466
|
Director | Form 4 | Conversion of derivative security | 2,700 | -- | -- |
| Jul 28, 2003 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 5,762 | $14.92 | 308,586 |
| Jun 26, 2003 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 5,332 | $15.89 | 314,348 |
| Jun 26, 2003 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 13,237 | $15.89 | 614,277 |
| May 07, 2003 |
Director
Trans History: 368
|
Director | Form 4 | Bona fide gift | 3,000 | $6.72 | 79,911 |
| Jan 13, 2003 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Bona fide gift | 250 | $19.65 | 15,482 |
| Feb 08, 2024 |
Vice President, Controller
Trans History: 6
|
Vice President, Controller | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | 4,204 |
| Feb 08, 2024 |
Vice President, Controller
Trans History: 6
|
Vice President, Controller | Form 3 | Initial Statement of Beneficial Ownership of Securities | 487 | -- | -- |
| Feb 08, 2024 |
Vice President, Controller
Trans History: 6
|
Vice President, Controller | Form 3 | Initial Statement of Beneficial Ownership of Securities | 1,905 | -- | -- |
| Feb 08, 2024 |
Vice President, Controller
Trans History: 6
|
Vice President, Controller | Form 3 | Initial Statement of Beneficial Ownership of Securities | 1,978 | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.